cannabis sativa flower extract é seguro durante a gravidez?
No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
Pregnancy-safe products containing cannabis sativa flower extract
Related ingredients
Frequently asked questions
- cannabis sativa flower extract é seguro durante a gravidez?
- No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
- cannabis sativa flower extract é seguro durante a amamentação?
- No authoritative classification or safety assessment (CIR/SCCS/ECHA harmonised) identifying breastfeeding-specific hazard for topical 'cannabis sativa flower extract'. Transfer to breast milk would require systemic absorption of cannabinoids; topical cosmetic use is expected to produce negligible maternal systemic levels. Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (systemic cannabinoid transfer studies noted but not applicable to low topical exposures).
- cannabis sativa flower extract é seguro para a pele do bebê?
- No evidence of intrinsic reproductive or developmental hazard of the botanical extract for infant topical use in authoritative sources. However, infant skin has higher per‑kg absorption and an immature barrier; if the extract contains measurable cannabinoids or other small lipophilic constituents there is potential for greater dermal uptake in 0–3 yr olds than adults. Therefore exposure score is increased by +1 (from adult negligible to low but measurable). Sources: CosIng (ingredient present in cosmetic inventories), general dermal absorption principles and PubMed literature on cannabinoid absorption (systemic effects relate to systemic exposure, not topical cosmetic use).
- Como o VeriMom pontua cannabis sativa flower extract?
- O VeriMom pontua cannabis sativa flower extract em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a cannabis sativa flower extract na gravidez?
- Veja nossa lista curada de alternativas seguras a cannabis sativa flower extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.
